LBF20307PG41: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
|LipidMaps=LMFA03010100 | |LipidMaps=LMFA03010100 | ||
|SysName= (5E, 13E) - (8R,12S,15S) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |SysName= (5E, 13E) - (8R,12S,15S) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | ||
|Common Name=&&5-trans-prostaglandin | |Common Name=&&5-trans-prostaglandin A2&& | ||
|Reflactive=[<FONT FACE="Symbol">a</FONT>]<SUB><FONT SIZE=-1>D</FONT></SUB> +128°(CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>)[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | |Reflactive=[<FONT FACE="Symbol">a</FONT>]<SUB><FONT SIZE=-1>D</FONT></SUB> +128°(CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>)[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | ||
|Mass Spectra=HREIMS m/z 478.2998 for TMS derivative C<SUB><FONT SIZE=-1>2</FONT></SUB><SUB><FONT SIZE=-1>6</FONT></SUB>H<SUB><FONT SIZE=-1>4</FONT></SUB><SUB><FONT SIZE=-1>6</FONT></SUB>O<SUB><FONT SIZE=-1>4</FONT></SUB> Si<SUB><FONT SIZE=-1>2</FONT></SUB>, calcd 478.2932.[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | |Mass Spectra=HREIMS m/z 478.2998 for TMS derivative C<SUB><FONT SIZE=-1>2</FONT></SUB><SUB><FONT SIZE=-1>6</FONT></SUB>H<SUB><FONT SIZE=-1>4</FONT></SUB><SUB><FONT SIZE=-1>6</FONT></SUB>O<SUB><FONT SIZE=-1>4</FONT></SUB> Si<SUB><FONT SIZE=-1>2</FONT></SUB>, calcd 478.2932.[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | ||
|UV Spectra=<FONT FACE="Symbol">l</FONT><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> 217 nm(<FONT FACE="Symbol">e</FONT>9050))[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | |UV Spectra=<FONT FACE="Symbol">l</FONT><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> 217 nm(<FONT FACE="Symbol">e</FONT>9050))[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | ||
}} | }} | ||
Revision as of 02:28, 18 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR8054 |
| LipidMaps | LMFA03010100 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20307PG41 |
| 5-trans-prostaglandin A2 | |
|---|---|
| |
| Structural Information | |
| (5E, 13E) - (8R,12S,15S) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
| Physicochemical Information | |
| Spectral Information | |
| Mass Spectra | HREIMS m/z 478.2998 for TMS derivative C26H46O4 Si2, calcd 478.2932. Bundy_GL et al. |
| UV Spectra | lmax 217 nm(e9050)) Bundy_GL et al. |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
